ReviewJournal of translational medicine2026
Unlocking the potential of EphA2 with precision-guided cancer therapy: bicycle drug conjugates.
Gavin Bennett et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it